4baseCare

4baseCare Transforming Precision Oncology in Asia.

๐Ÿ’ซ Our CEO Hitesh Goswami, COO Ksh*tij Rishi and CDO Puneet Pantane at the Memorial Sloan Kettering Cancer Center Demo Da...
03/12/2025

๐Ÿ’ซ Our CEO Hitesh Goswami, COO Ksh*tij Rishi and CDO Puneet Pantane at the Memorial Sloan Kettering Cancer Center Demo Day for MSK Therapeutics Accelerator & Memorial Sloan Kettering Cancer Center iHub Challenge 2025 Cohort programโ€™ being held at The Rockefeller University auditorium !

4baseCare has been selected to join the MSK Innovation Hub Challenge 2025 Cohort at Memorial Sloan Kettering Cancer Center (MSK), USA.

๐Ÿ‘‰ This milestone allows us to:-

Validate our OncoTwin Insights platform on 30,000 deidentified patient records from MSK, in pursuit of our plan to make the platform clinic-ready for doctors worldwide.

Explore potential solutions that not only address various cancer types, but also empower doctors in India and emerging markets with real-world evidence to guide treatment.

Support our patient-first mission globally, bringing affordable and equitable innovations to underserved communities.

๐Ÿ’ก ๐“๐š๐ซ๐†๐“ ๐…๐ข๐ซ๐ฌ๐ญ ๐ฃ๐ฎ๐ฌ๐ญ ๐ฅ๐ž๐ฏ๐ž๐ฅ๐ฅ๐ž๐ ๐ฎ๐ฉ ๐Ÿ๐ซ๐จ๐ฆ 72 ๐ญ๐จ 92 ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ๐ฅ๐ฒ ๐ซ๐ž๐ฅ๐ž๐ฏ๐š๐ง๐ญ ๐ ๐ž๐ง๐ž๐ฌ!๐Ÿงฌ Upgraded genes :ESR1 | HRAS | PIK3R1 | TERT | A...
27/11/2025

๐Ÿ’ก ๐“๐š๐ซ๐†๐“ ๐…๐ข๐ซ๐ฌ๐ญ ๐ฃ๐ฎ๐ฌ๐ญ ๐ฅ๐ž๐ฏ๐ž๐ฅ๐ฅ๐ž๐ ๐ฎ๐ฉ ๐Ÿ๐ซ๐จ๐ฆ 72 ๐ญ๐จ 92 ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ๐ฅ๐ฒ ๐ซ๐ž๐ฅ๐ž๐ฏ๐š๐ง๐ญ ๐ ๐ž๐ง๐ž๐ฌ!

๐Ÿงฌ Upgraded genes :

ESR1 | HRAS | PIK3R1 | TERT | AKT1 | CCND1 | PPP2R2A | FANCA | MRE11 (MRE11A) | NBN | DPYD | TPMT | UGT1A1 | ERBB4 | FGFR4 | ATR | H3-3A | H3C2 | NF1 | NF2 PIK3R1 | TERT | CCND1 | PPP2R2A | FANCA | MRE11 (MRE11A) | NBN | DPYD | TPMT | ERBB4 | ATR | H3-3A | H3C2 | NF1 | NF2

Our focused, fast, and affordable panel now expands from 72 to 92 clinically relevant genes - bringing even more actionable precision to every patient journey.

Every gene we add is another chance to guide treatment better, earlier, and smarter.

Precision shouldnโ€™t be a privilege. It should be accessible.

๐Ÿ”ฌ Find the full list of upgraded genes in the caption below.

๐Ÿ’ซ๐‡๐จ๐ง๐จ๐ฎ๐ซ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐„๐’๐Œ๐Ž - ๐„๐ฎ๐ซ๐จ๐ฉ๐ž๐š๐ง ๐’๐จ๐œ๐ข๐ž๐ญ๐ฒ ๐Ÿ๐จ๐ซ ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐Ž๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ ๐†๐ฎ๐ฅ๐Ÿ 2025 ๐š๐ง๐ ๐œ๐จ๐ง๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ž ๐ญ๐จ ๐ฌ๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฉ๐ซ๐ž๐œ๐ข...
24/11/2025

๐Ÿ’ซ๐‡๐จ๐ง๐จ๐ฎ๐ซ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐„๐’๐Œ๐Ž - ๐„๐ฎ๐ซ๐จ๐ฉ๐ž๐š๐ง ๐’๐จ๐œ๐ข๐ž๐ญ๐ฒ ๐Ÿ๐จ๐ซ ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐Ž๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ ๐†๐ฎ๐ฅ๐Ÿ 2025 ๐š๐ง๐ ๐œ๐จ๐ง๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ž ๐ญ๐จ ๐ฌ๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฉ๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐จ๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ ๐ฅ๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž ๐š๐œ๐ซ๐จ๐ฌ๐ฌ ๐ญ๐ก๐ž ๐Œ๐ข๐๐๐ฅ๐ž ๐„๐š๐ฌ๐ญ.

Grateful to the Emirates Oncology Society. We look forward to impactful conversations and collaboration that accelerates access to precision oncology.

Together, we beat cancer!

๐Ÿงฌ 4baseCare ๐ฉ๐ซ๐จ๐ฎ๐ ๐ญ๐จ ๐ซ๐ž๐œ๐ž๐ข๐ฏ๐ž ๐ญ๐ก๐ž ๐€๐ฉ๐ฉ๐ซ๐ž๐œ๐ข๐š๐ญ๐ข๐จ๐ง ๐€๐ฐ๐š๐ซ๐ ๐š๐ฌ ๐š ๐’๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ ๐’๐ฉ๐จ๐ง๐ฌ๐จ๐ซ ๐š๐ญ ๐๐ž๐ฌ๐ญ ๐จ๐Ÿ ๐„๐’๐Œ๐Ž ๐†๐ฎ๐ฅ๐Ÿ 2025, ๐ก๐ž๐ฅ๐ ๐š๐ญ ๐ญ๐ก๐ž Grand Pl...
24/11/2025

๐Ÿงฌ 4baseCare ๐ฉ๐ซ๐จ๐ฎ๐ ๐ญ๐จ ๐ซ๐ž๐œ๐ž๐ข๐ฏ๐ž ๐ญ๐ก๐ž ๐€๐ฉ๐ฉ๐ซ๐ž๐œ๐ข๐š๐ญ๐ข๐จ๐ง ๐€๐ฐ๐š๐ซ๐ ๐š๐ฌ ๐š ๐’๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ ๐’๐ฉ๐จ๐ง๐ฌ๐จ๐ซ ๐š๐ญ ๐๐ž๐ฌ๐ญ ๐จ๐Ÿ ๐„๐’๐Œ๐Ž ๐†๐ฎ๐ฅ๐Ÿ 2025, ๐ก๐ž๐ฅ๐ ๐š๐ญ ๐ญ๐ก๐ž Grand Plaza Mรถvenpick Media City, .

A moment on this stage represents the growing collaborations in the Gulf region in advancing precision oncology. Weโ€™re committed to supporting here with cutting-edge genomic insights that enable personalised, data-driven cancer care.

A heartfelt thank you to the organisers, faculty, for welcoming us and recognising the work we are building across the region.

๐Ÿ‘‰ Hereโ€™s to deeper partnerships, stronger scientific exchange, and improved outcomes for patients across the Gulf.

Together, We Beat Cancer!

Innovate Life Sciences-Fz-LLC

๐Ÿ’ซ ๐๐š๐ง๐œ๐ซ๐ž๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐Œ๐จ๐ง๐ญ๐ก Precision isnโ€™t optional in pancreatic cancer. itโ€™s the difference between guesswork...
21/11/2025

๐Ÿ’ซ ๐๐š๐ง๐œ๐ซ๐ž๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐Œ๐จ๐ง๐ญ๐ก

Precision isnโ€™t optional in pancreatic cancer. itโ€™s the difference between guesswork and actionable insight.

Our publication analysed 261 Indian patients using a 1212-gene panel, revealing distinct genomic patterns that can shape more informed treatment decisions for this aggressive disease.

This is data built for impact.

This is why genomic testing matters !

๐Ÿ”— Read more from our published article- https://lnkd.in/g7c2Hu5B

20/11/2025

๐–๐ก๐š๐ญ ๐ข๐Ÿ ๐š๐ง ๐€๐ˆ ๐œ๐จ๐ฎ๐ฅ๐ ๐ญ๐ซ๐ฎ๐ฅ๐ฒ ๐œ๐š๐ซ๐ž?

What if it could understand your journey, learn from patients just like you, and identify what treatments have worked for people with your same and molecular pathways?

๐Ÿ‘‰With , that future is now.

Your digital twin analyses shared genomic patterns, uncovers personalised clinico-genomic insights, and empowers your care team with data that truly matters.

This is AI-driven cancer care -smarter, more personal, and built around you.

๐“๐จ๐ ๐ž๐ญ๐ก๐ž๐ซ, ๐–๐ž ๐๐ž๐š๐ญ ๐‚๐š๐ง๐œ๐ž๐ซ

๐“๐ก๐ž ๐ฐ๐จ๐ซ๐ฅ๐ ๐จ๐Ÿ  #๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ก๐š๐ฌ ๐ ๐ซ๐จ๐ฐ๐ง ๐Ÿ๐š๐ซ ๐›๐ž๐ฒ๐จ๐ง๐ โ€œ #๐‡๐„๐‘2-๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐žโ€ ๐จ๐ซ โ€œ #๐„๐†๐…๐‘-๐ฆ๐ฎ๐ญ๐š๐ญ๐ž๐.โ€We now read rare fusions like   and...
18/11/2025

๐“๐ก๐ž ๐ฐ๐จ๐ซ๐ฅ๐ ๐จ๐Ÿ #๐›๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐ก๐š๐ฌ ๐ ๐ซ๐จ๐ฐ๐ง ๐Ÿ๐š๐ซ ๐›๐ž๐ฒ๐จ๐ง๐ โ€œ #๐‡๐„๐‘2-๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐žโ€ ๐จ๐ซ โ€œ #๐„๐†๐…๐‘-๐ฆ๐ฎ๐ญ๐š๐ญ๐ž๐.โ€

We now read rare fusions like and , protein markers like .2, tumour behaviour indicators like and , and even , which can spot recurrence months before imaging.

Every one of these markers shifts cancer care from โ€œone-size-fits-allโ€ to something far more humane: precision.

At , we work to make these insights accessible across and -through comprehensive genomic profiling, liquid biopsy, digital twin modelling, and population-specific panels that represent our regionโ€™s unique cancer biology.

Hereโ€™s to the biomarkers that whisper the truth about cancer - and to the science that listens !

14/11/2025

เค•เฅˆเค‚เคธเคฐ เค•เฅ‡ เค‡เคฒเคพเคœ เค•เฅ‡ เคฆเฅŒเคฐเคพเคจ เค–เคพเคจเคพ เค”เคฐ เคฎเคพเคจเคธเคฟเค• เคธเฅเคตเคพเคธเฅเคฅเฅเคฏ โ€” เคฆเฅ‹เคจเฅ‹เค‚ เค•เคพ เคงเฅเคฏเคพเคจ เคฐเค–เคจเคพ เคฌเคนเฅเคค เคœเคผเคฐเฅ‚เคฐเฅ€ เคนเฅ‹เคคเคพ เคนเฅˆเฅค
เค‡เคธเฅ€ เคฌเคพเคค เค•เฅ‹ เคธเคฎเคเคพเคจเฅ‡ เค•เฅ‡ เคฒเคฟเค เคนเคฎ เคเค• เค–เคพเคธ เคธเคคเฅเคฐ เคฒเฅ‡เค•เคฐ เค† เคฐเคนเฅ‡ เคนเฅˆเค‚, เคœเคนเคพเค เคนเคฎเคพเคฐเฅ‡ เคตเคฟเคถเฅ‡เคทเคœเฅเคž เคฌเคคเคพเคเคเค—เฅ‡ เค•เคฟ เคธเคนเฅ€ เค–เคพเคจเคชเคพเคจ เค”เคฐ เคฎเคจ เค•เฅ€ เคฆเฅ‡เค–เคญเคพเคฒ เค•เฅˆเคธเฅ‡ เคฎเคฐเฅ€เคœ เค•เฅ€ เคชเฅ‚เคฐเฅ€ เค‰เคชเคšเคพเคฐ เคฏเคพเคคเฅเคฐเคพ เค•เฅ‹ เค†เคธเคพเคจ เค”เคฐ เคฌเฅ‡เคนเคคเคฐ เคฌเคจเคพ เคธเค•เคคเฅ‡ เคนเฅˆเค‚เฅค

เค‡เคธ เคฒเคพเค‡เคต เคธเคคเฅเคฐ เคฎเฅ‡เค‚ เคนเคฎ เคฌเคพเคค เค•เคฐเฅ‡เค‚เค—เฅ‡:
โ€ข เค‡เคฒเคพเคœ เค•เฅ‡ เคธเคฎเคฏ เคชเฅ‹เคทเคฃ เค”เคฐ เคฎเคจเฅ‹เคฌเคฒ เค•เคพ เคฐเคฟเคถเฅเคคเคพ
โ€ข เคฎเคฐเฅ€เคœเฅ‹เค‚ เค•เฅ‹ เค†เคจเฅ‡ เคตเคพเคฒเฅ€ เค†เคฎ เคฆเคฟเค•เฅเค•เคคเฅ‡เค‚
โ€ข เค”เคฐ เค†เคธเคพเคจ, เค‰เคชเคฏเฅ‹เค—เฅ€ เคธเคฎเคพเคงเคพเคจ

๐Ÿ“… เคคเคพเคฐเฅ€เค–: 14 เคจเคตเค‚เคฌเคฐ
โฐ เคธเคฎเคฏ: เคถเคพเคฎ 4:00 เคฌเคœเฅ‡ โ€“ 5:00 เคฌเคœเฅ‡ (IST)

#เคชเฅ‹เคทเคฃเคธเฅ‡เคธเฅเค•เฅ‚เคจเคคเค• #เค•เฅˆเค‚เคธเคฐเคฆเฅ‡เค–เคญเคพเคฒ #เคฎเคพเคจเคธเคฟเค•เคธเฅเคตเคพเคธเฅเคฅเฅเคฏเคฎเคนเคคเฅเคตเคชเฅ‚เคฐเฅเคฃเคนเฅˆ #เคชเฅ‹เคทเคฃเค”เคฐเคฎเคจ #เคชเฅ‹เคทเคฃเคธเฅ‡เค‰เคชเคšเคพเคฐ #เค‘เคจเฅเค•เฅ‹เค•เฅ‡เคฏเคฐ
#เคธเฅเคตเคพเคธเฅเคฅเฅเคฏเค•เฅ€เคฏเคพเคคเฅเคฐเคพ #เคธเค•เคพเคฐเคพเคคเฅเคฎเค•เคฎเคจเคธเค•เคพเคฐเคพเคคเฅเคฎเค•เคœเฅ€เคตเคจ #เคธเฅเคตเคพเคธเฅเคฅเฅเคฏเคตเคฐเฅเคงเค•เค†เคนเคพเคฐ #เค•เฅˆเค‚เคธเคฐเคœเคพเค—เคฐเฅ‚เค•เคคเคพ #เคฐเฅ‹เค—เฅ€เคฆเฅ‡เค–เคญเคพเคฒ
#เคธเคฎเค—เฅเคฐเค‰เคชเคšเคพเคฐ #เคฎเคจเค”เคฐเคถเคฐเฅ€เคฐเค•เคพเคธเค‚เคคเฅเคฒเคจ #เคฎเคพเคจเคธเคฟเค•เคธเฅเคตเคพเคธเฅเคฅเฅเคฏ #เค‘เคจเฅเค•เฅ‹เคฌเคกเฅ€ #เคฏเฅ‹เคฆเฅเคงเคพเค“เค‚เค•เฅ‡เคธเคพเคฅ #เคœเฅ€เคตเคจเค•เฅ‡เคฒเคฟเคเคชเฅ‹เคทเคฃ #เคฎเคพเคจเคธเคฟเค•เคธเฅเคตเคพเคธเฅเคฅเฅเคฏเคœเคพเค—เคฐเฅ‚เค•เคคเคพ #เคฎเคฟเคฒเค•เคฐเค‰เคชเคšเคพเคฐ

๐Ÿ”ฌ ๐‰๐จ๐ข๐ง ๐”๐ฌ ๐ข๐ง ๐‘๐ž๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ข๐ฌ๐ข๐ง๐  ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž ๐š๐ญ @4๐›๐š๐ฌ๐ž๐œ๐š๐ซ๐ž!At , weโ€™re driven by one purpose - to make cancer treatment truly...
13/11/2025

๐Ÿ”ฌ ๐‰๐จ๐ข๐ง ๐”๐ฌ ๐ข๐ง ๐‘๐ž๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ข๐ฌ๐ข๐ง๐  ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž ๐š๐ญ @4๐›๐š๐ฌ๐ž๐œ๐š๐ซ๐ž!

At , weโ€™re driven by one purpose - to make cancer treatment truly personal. We develop cutting-edge genomics and digital health solutions that empower oncologists to provide precision care for every patient.

Weโ€™re expanding our team and looking for passionate individuals who want to make a real impact in the fight against cancer.

๐Ÿ’ผ Open Roles:

๐Ÿ‘‰๐๐ข๐จ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐œ๐ฌ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ

๐Ÿ‘‰๐’๐ž๐ง๐ข๐จ๐ซ ๐…๐ฎ๐ฅ๐ฅ ๐’๐ญ๐š๐œ๐ค ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ž๐ซ

๐Ÿ‘‰๐…๐ฎ๐ฅ๐ฅ ๐’๐ญ๐š๐œ๐ค ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ž๐ซ (๐…๐ซ๐ž๐ฌ๐ก๐ž๐ซ)

Here, science meets technology to create solutions that save lives. If you believe in the power of innovation, data, and compassion to transform healthcare - weโ€™d love to work with you.

๐Ÿ“ฉ Apply now at careers@4basecare.com and be part of a mission that matters.
Together, letโ€™s shape the future of personalised cancer care. ๐Ÿ™Œ๐Ÿงฌ๐ŸŽ—๏ธ

โœจ๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐š๐Ÿ๐Ÿ๐จ๐ซ๐๐š๐›๐ข๐ฅ๐ข๐ญ๐ฒ ๐š๐ง๐ ๐š๐œ๐œ๐ž๐ฌ๐ฌ๐ข๐›๐ข๐ฅ๐ข๐ญ๐ฒ ๐ข๐ง ๐‹๐ฎ๐ง๐  ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐‹๐ฎ๐๐†๐’ ๐€๐ฅ๐ฅ๐ข๐š๐ง๐œ๐ž - an initiative by CRSF - Cancer Resear...
12/11/2025

โœจ๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐š๐Ÿ๐Ÿ๐จ๐ซ๐๐š๐›๐ข๐ฅ๐ข๐ญ๐ฒ ๐š๐ง๐ ๐š๐œ๐œ๐ž๐ฌ๐ฌ๐ข๐›๐ข๐ฅ๐ข๐ญ๐ฒ ๐ข๐ง ๐‹๐ฎ๐ง๐  ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐‹๐ฎ๐๐†๐’ ๐€๐ฅ๐ฅ๐ข๐š๐ง๐œ๐ž - an initiative by CRSF - Cancer Research and Statistic Foundation, supported by AstraZeneca, Pfizer, Roche, Bristol Myers Squibb and Eli Lilly and Company with proud lab partner 4baseCare

Lung cancer remains one of the most challenging cancers to diagnose and treat. But, and can change so much !

Through the LuNGS Alliance, weโ€™re making next-generation sequencing ( ) accessible to lung cancer patients across - empowering oncologists with genomic insights that guide the right treatment, at the right time.

๐Ÿ‘‰Learn more about LuNGS Alliance | Breathe in knowledge. Breathe out fear ๐Ÿ’ซ

๐Ÿ“ž For assistance: 1800-202-2455

๐Ÿ”— Visit www.crsf.in to download the test request form.

Together, we beat cancer !

๐€ ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ๐ก๐ข๐ฉ ๐ฐ๐ข๐ญ๐ก ๐˜๐š๐ฅ๐ข ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅ ๐›๐ซ๐ข๐ง๐ ๐ฌ ๐ญ๐จ๐ ๐ž๐ญ๐ก๐ž๐ซ  #๐ฏ๐ข๐ฌ๐ข๐จ๐ง,  #๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง, ๐š๐ง๐ ๐๐ž๐ž๐ฉ-๐ญ๐ž๐œ๐ก ๐š๐ฆ๐›๐ข๐ญ๐ข๐จ๐ง !๐Ÿ’ซ What makes this partne...
11/11/2025

๐€ ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ๐ก๐ข๐ฉ ๐ฐ๐ข๐ญ๐ก ๐˜๐š๐ฅ๐ข ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅ ๐›๐ซ๐ข๐ง๐ ๐ฌ ๐ญ๐จ๐ ๐ž๐ญ๐ก๐ž๐ซ #๐ฏ๐ข๐ฌ๐ข๐จ๐ง, #๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง, ๐š๐ง๐ ๐๐ž๐ž๐ฉ-๐ญ๐ž๐œ๐ก ๐š๐ฆ๐›๐ข๐ญ๐ข๐จ๐ง !

๐Ÿ’ซ What makes this partnership even more special is when you look closer at the logo and decipher the meaning behind the Yali Capital logo itself !

๐Ÿงฌ The DNA helix reflects their commitment to Genomics and Life Sciences- championing companies like ours- 4baseCare.

๐Ÿ’ซ The aircraft and tech motifs highlight their investment focus across , , , and other breakthrough technologies !

๐Ÿš€ Hereโ€™s to bold ideas, innovative thought, soaring innovation and building a brighter future with Yali Capital ! In the spotlight- Ganapathy Subramaniam & Kaushik Ram , Ph.D.with Hitesh Goswami and Ksh*tij Rishi๐Ÿš€

Address

No. 78/9, Outer Ring Road, Bellandur Village Varthur Hobli Bengaluru East Ground Floor, Bengaluru Bioinnovation Centre, Helix Biotech Park, Electronics City Phase 1, Bengaluru 560100
Bangalore
560103

Alerts

Be the first to know and let us send you an email when 4baseCare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to 4baseCare:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram